Ever year, an estimated 6 to 12 million children get head lice, leading to questions about missed school and work.

Swiss medicines authority issues first approval for antimalarial drug for treatment of infants Switzerland’s medical products authority has granted the first approval for a malaria medicine ...

GENEVA (AP) — Switzerland’s medical products authority has granted the first approval for a malaria medicine designed for small infants, touted as an advance against a disease that takes ...

Still, she said it was “significant to finally have a suitable and safe treatment for very young children — more than 20 years since WHO first pre-qualified Coartem for older age groups.

Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis.

The meeting included a discussion of thimerosal, a mercury-based preservative and longtime target of the anti-vaccine world. It was removed from nearly all U.S. vaccines in 2001.

Alphabet’s Calico is inking a deal worth up to $571 million biobucks for rights to Mabwell's IL-11-targeting mAb for age-related diseases.

Patients with head lice may initially be asymptomatic, but the problem can quickly snowball, so timely diagnosis and thorough treatment are essential.

An international researcher team of Louisiana Tech University, Gubkin University [also known as, Gubkin Russian State University of Oil and Gas] and Kazan Federal University reported the fabrication ...